azathioprine has been researched along with Leukemia, Smoldering in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient was given a diagnosis of refractory anemia with excess of blasts in transformation (RAEB in T), and treated with idarubicin and cytosine arabinoside." | 2.40 | [Myelodysplastic syndrome (RAEB in T) developed in a renal allograft recipient]. ( Akiyama, M; Inaba, T; Katori, Y; Maki, K; Nakagawa, M; Sawada, K; Shimazaki, C; Shiraishi, J; Sudo, Y; Takada, O, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shiraishi, J | 1 |
| Sudo, Y | 1 |
| Katori, Y | 1 |
| Akiyama, M | 1 |
| Takada, O | 1 |
| Maki, K | 1 |
| Sawada, K | 1 |
| Inaba, T | 1 |
| Shimazaki, C | 1 |
| Nakagawa, M | 1 |
1 review available for azathioprine and Leukemia, Smoldering
| Article | Year |
|---|---|
[Myelodysplastic syndrome (RAEB in T) developed in a renal allograft recipient].
Topics: Anemia, Refractory, with Excess of Blasts; Azathioprine; Humans; Immunosuppressive Agents; Kidney Ne | 1998 |